98%
921
2 minutes
20
Introduction: Traumatic brain injury (TBI), caused by external force to the head, leads to anatomical or functional damage to cranial structures. It is a leading cause of morbidity and mortality in adults worldwide, with substantial economic burden. Post-traumatic epilepsy (PTE) is a significant complication of TBI, posing immense challenges to rehabilitation and exacerbating socioeconomic burdens. The incidence of PTE varies widely, underscoring the need for early detection and treatment.
Objective: Through prospective electroencephalography (EEG) evaluations over a two-year period, our study aims to identify electrographic patterns indicative of PTE development, offering crucial insights for timely intervention and improved patient outcomes.
Methods: Seventy-three adult participants with acute TBI, admitted to a reference hospital in Brazil between 2018 and 2020, were recruited based on eligibility criteria. EEG evaluations monitored seizure occurrence with follow-ups for up to 24 months post-TBI, though these were disrupted by the COVID-19 pandemic. Analyses included established EEG protocols, examining factors such as background activity and epileptiform paroxysms. Relative risk (RR), Multiple Correspondence Analysis (MCA), logistic regression, and Generalized Estimating Equations (GEE) were employed to predict variables associated with PTE development.
Results: Both PTE and NO-PTE (no post-traumatic epilepsy) patients showed improving background activity over 2 years. EEG recordings revealed that injuries in the temporal region, diffuse theta waves and abnormal bilateral sleep elements indicated a higher risk of PTE development. Additionally, multiple lesions were also associated with PTE.
Conclusion: This comprehensive approach provides valuable insights for clinical management and sheds light on the complex interplay of factors influencing TBI outcomes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12332879 | PMC |
http://dx.doi.org/10.3389/fneur.2025.1609733 | DOI Listing |
Neurochem Res
September 2025
Department of Physiology, Hamidiye Faculty of Medicine, University of Health Sciences, Istanbul, Turkey.
The aim of the presented study was to investigate the effects of prebiotic inulin, probiotic VSL#3 (mixture of bacteria from 7 different species and 8 strains) and synbiotic (inulin + VSL#3) supplements applied together with lacosamide (LCM) on post-traumatic epilepsy (PTE). In addition, effectiveness of the relevant treatments on comorbid problems related to learning and memory, anxiety, motor performance and pain threshold that may develop together with seizures due to traumatic brain injury (TBI) and PTE was also examined using behavioral tests. In experiments, adult male Sprague-Dawley rats, divided into 6 groups, were given 30 mg/kg LCM or 1000 mg/kg inulin together with LCM as prebiotic, VSL#3 mixture containing 10 × 10 CFU/kg bacterial colonies as probiotic and (inulin + VSL#3) as synbiotic for 28 days by oral gavage after mild-TBI was induced by weight-drop method and electroencephalogram electrodes were placed.
View Article and Find Full Text PDFEpilepsy Behav Rep
December 2025
Kern Medical, Bakersfield, CA, USA.
While many patients treated with Responsive Neurostimulation (RNS) experience a significant reduction in seizures, poor responders to traditional high frequency stimulation (HFS) may experience a meaningful reduction in seizure frequency when switched to low frequency stimulation (LFS). This case report presents a patient who developed post-traumatic pharmacoresistant bitemporal epilepsy and underwent unsuccessful treatments, including antiseizure polytherapy and implantation of a vagus nerve stimulator (VNS). Due to ongoing seizures, the patient underwent RNS System implantation with bilateral hippocampal depth electrodes.
View Article and Find Full Text PDFNaunyn Schmiedebergs Arch Pharmacol
August 2025
Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar-143005, India.
Mirtazapine (MTZ) is a Food and Drug Administration-approved medication used primarily for the treatment of severe depression. It is a BCS class II drug having poor aqueous solubility (0.092 mg/mL), low oral bioavailability (50%), and high first-pass metabolism.
View Article and Find Full Text PDFNeuroscience
August 2025
School Of Nursing, Lanzhou University, Lanzhou, Gansu 730000, PR China; Department of Nursing, Lanzhou University Second Hospital, Lanzhou, Gansu 730030, PR China. Electronic address:
Background: Posttraumatic epilepsy (PTE) is a major concern after traumatic brain injury (TBI).
Objective: This systematic review and meta-analysis estimated the global prevalence of PTE in TBI patients.
Methods: The study systematically searched relevant studies published from inception to September 20, 2024, using PubMed, Embase, Cochrane Library and Web of Science.
BMJ Open
August 2025
Department of Emergency and Critical Care Medicine, Keio University School of Medicine, Tokyo, Japan.
Introduction: Traumatic brain injury (TBI) often causes permanent neurological dysfunction. Although no medication has been validated yet to prevent secondary injury of brain tissue, recent animal studies have reported that perampanel, a glutamine receptor antagonist, could improve the neurological functions of animals with TBI by mitigating the abnormal calcium influx and cell death around the site of primary injury. The present study aims to elucidate the efficacy of perampanel administration in improving the neurological function of patients with TBI.
View Article and Find Full Text PDF